[
  {
    "ts": null,
    "headline": "The London Company Income Equity Q3 2024 Portfolio Commentary",
    "summary": "The London Company Income Equity portfolio gained 10.5% (10.4% net) during the quarter vs. a 9.4% increase in the Russell 1000 Value Index.",
    "url": "https://finnhub.io/api/news?id=3ab61232f5b20136887a54f8f535a5396e52c026f2155d51460d6a8d767db436",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732918800,
      "headline": "The London Company Income Equity Q3 2024 Portfolio Commentary",
      "id": 131716802,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1408404108/image_1408404108.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The London Company Income Equity portfolio gained 10.5% (10.4% net) during the quarter vs. a 9.4% increase in the Russell 1000 Value Index.",
      "url": "https://finnhub.io/api/news?id=3ab61232f5b20136887a54f8f535a5396e52c026f2155d51460d6a8d767db436"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock underperforms Friday when compared to competitors",
    "summary": "Merck & Co. Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=aa24ef0ecda9963f89ef5fb7fb717999dd76cc91d750d2d641335bea94b9d5fb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732898100,
      "headline": "Merck & Co. Inc. stock underperforms Friday when compared to competitors",
      "id": 131775681,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=aa24ef0ecda9963f89ef5fb7fb717999dd76cc91d750d2d641335bea94b9d5fb"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q3 2024 Commentary",
    "summary": "The Janus Henderson Global Life Sciences Diversified ADR Managed AccountÂ Portfolio returned 5.74% (gross) for Q3 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=d13820debe5090781df5f64d03a4e6366609fc54e420fcea29eb851f7981fff8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732841400,
      "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q3 2024 Commentary",
      "id": 131700113,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1633433467/image_1633433467.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The Janus Henderson Global Life Sciences Diversified ADR Managed AccountÂ Portfolio returned 5.74% (gross) for Q3 2024. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=d13820debe5090781df5f64d03a4e6366609fc54e420fcea29eb851f7981fff8"
    }
  }
]